yeah thats a fair point, but statins must be taken everyday...

yeah thats a fair point, but statins must be taken everyday whereas ApoA infusions would most likely be required far less often. In addition ApoA infusions would be far more efficacious since they actively remove lipids from foam cells in atheromas instead of just slowing the synthesis of more LDL's - so may be useful in more complex/severe cases. Ofcourse this is just speculation - we dont even know for sure yet whether these apoA infusions can even reduce the likelihood of a recurrent MI.
In either way it's still a very long time till the results of the aegisII trial, let alone further research into csl112's applications.